Methods and compositions of (2R,4S) itraconazole for treating fungal yeast and dermatophyte infections
US5474997A · kind A · utility
48Cited by
2References
15Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 17, 1994 |
| Grant date | Dec 12, 1995 |
| Priority date | — |
| Expiry date | Nov 17, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods and compositions are disclosed utilizing the optically pure (2R,4S) isomer of itraconazole. This compound is a potent drug for the treatment of local and systemic fungal, yeast, and dermatophyte infections, while avoiding the concomitant liability of adverse effects associated with the racemic mixture of itraconazole.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.